Supplementary Figure 2 from HGF as a Circulating Biomarker of Onartuzumab Treatment in Patients with Advanced Solid Tumors

Autor:	Priti S. Hegde, Mark R. Lackner, Garret M. Hampton, Amy Peterson, Premal Patel, Robert L. Yauch, Mark Merchant, Kyra J. Cowan, Luciana Burton, Vaishali Parab, Congfen Li, Elicia Penuel
Rok vydání:	2023
DOI:	10.1158/1535-7163.22499676
Popis:	PDF file - 24K, cHGF levels are stable over time and are not variable between screening (any time during visit -24 hours) and predose (Day 0).
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::754e28d16bdf0548b4252eaebc7b8e2b https://doi.org/10.1158/1535-7163.22499676 Zobrazit plný text záznamu